호모시스틴뇨증 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00026172
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 226
Buy Now

호모시스틴뇨증 시장은 2021년 5,658만 달러에서 2028년 7,396만 달러에 이를 것으로 예상됩니다. 2021-2028년 동안 CAGR 3.9%로 성장할 것으로 추정됩니다.



호모시스틴뇨증은 신체가 특정 단백질 구성 요소(아미노산)를 올바르게 소화할 수 없는 유전적 상태입니다. 호모시스틴뇨증은 다양한 유형으로 나타나며 각각 고유한 징후와 증상 및 유전적 병인이 있습니다. 근시(근시), 눈 앞쪽의 수정체 탈구, 불규칙한 혈액 응고의 더 큰 위험, 부러지기 쉬운 뼈(골다공증) 또는 기타 골격 이상이 호모시스틴뇨증의 가장 일반적인 형태를 정의합니다. 영향을 받는 일부 사람들은 발달 지연과 학습 장애도 있습니다.



전략적 통찰력



호모시스틴뇨증 시장의 성장은 비타민 B6와 비타민 B12의 결핍이 증가하고 유전성 대사 장애의 증가하는 유병률. 그러나 다양한 희귀 질환 및 유전성 대사 장애에 대한 인식 부족은 시장 성장을 방해합니다.



호모시스틴뇨증 시장의 수익성 있는 지역



시장 통찰력비타민 B6 및 비타민 B12 결핍증이 호모시스틴뇨증 시장을 주도< /h3>

비타민 B6 및 비타민 B12 결핍 패턴의 증가는 빈혈, 거대 적아구성 빈혈, 소적혈구 빈혈 및 일부 대사 장애와 같은 여러 장애로 이어지며, 이는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다. 비타민 B6 요법은 호모시스틴뇨증에 대한 효과적인 치료법으로 여겨지므로 이 비타민의 결핍은 상태를 악화시킬 수 있습니다. 피리독신(비타민 B6)은 베타 합성 효소의 보조인자 역할을 하며 여러 미스센스 돌연변이를 안정화시키는 샤페론 역할을 합니다. 호모시스틴뇨증이 있는 일부 환자는 피리독신 요법에 잘 반응하며 호모시스테인 수치를 낮추는 데 도움이 되므로 상태가 완화됩니다. 따라서 호모시스틴뇨증을 치료하는 데 사용할 수 있는 치료법이 제한되어 있기 때문에 비타민 B6는 호모시스틴뇨증 관리에 필수적인 것으로 간주됩니다. 이 효소의 결핍은 빈혈 및 소적혈구성 빈혈을 유발합니다. 빈혈의 유병률 증가는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, 세계보건기구에 따르면 빈혈은 16억 2천만 명 이상의 인구, 즉 인구의 24.8%에 영향을 미칩니다. 빈혈의 주요 원인은 부적절한 식습관과 B6, B9, B12와 같은 비타민 결핍입니다. 주로 비타민 B6 결핍은 빈혈의 주요 원인입니다. 따라서 비타민 B6 결핍 사례의 증가와 결핍과 관련된 장애의 높은 유병률은 예측 기간 동안 시장 성장을 뒷받침할 것으로 예상됩니다.



방법 기반 통찰력



The 전 세계 호모시스틴뇨증 시장은 방법에 따라 치료와 진단으로 양분된다. 치료 부문은 2021년에 시장에서 더 큰 점유율을 차지했습니다. 더욱이, 동일한 부문은 현재 치료의 사용과 호모시스틴뇨증에 대한 새로운 치료법의 연구 및 개발 증가로 인해 예측 기간 동안 시장에서 더 높은 CAGR을 기록할 것으로 예상됩니다.



방법별 호모시스틴뇨증 시장 - 2021년 및 2028년



최종 사용자 기반 통찰력



최종 사용자를 기반으로 하는 글로벌 호모시스틴뇨증 시장은 다음과 같이 분류됩니다. 진단 및 이미징 실험실, 병원 및 진료소, 전문 진료소, 학술 및 연구 기관. 2021년에는 진단 및 이미징 실험실 부문이 시장에서 가장 큰 점유율을 차지했습니다. 또한 진단 및 이미징 실험실에서 유전성 대사 장애 진단이 증가함에 따라 이 부문은 2021-2028년 동안 4.2%의 가장 높은 CAGR을 기록할 것으로 예상됩니다.



제품 출시 및 승인은 회사에서 일반적으로 채택하는 전략입니다. 글로벌 입지와 제품 포트폴리오를 확장합니다. 또한 호모시스틴뇨증 시장 참가자는 고객 확대를 위한 파트너십 전략에 초점을 맞추고 있으며, 이를 통해 전 세계적으로 브랜드 이름을 유지할 수 있습니다.



보고서는 호모시스틴뇨증 시장을 다음과 같이 분류합니다



호모시스틴뇨증 시장 - 방법별





  • 치료

    • 피리독신

    • 베타인

    • 기타



  • 진단

    • 유전자 검사

    • 아미노산 선별 검사

    • 간 효소 검사

    • 기타

    • < /ul>

    호모시스틴뇨증 시장 - 최종 사용자별





    • 병원 및 진료소

    • 진단 및 영상 연구소

    • 전문 클리닉

    • 학술 및 연구 기관


    호모시스틴뇨증 시장 – 지역별





    • 북미

      • US< /li>
      • 캐나다

      • 멕시코



    • 유럽

      • 영국

      • 독일

      • 프랑스

      • 이탈리아

      • 스페인

      • 기타 유럽



    • 아시아 태평양

      • 중국

      • 일본

      • 인도

      • 호주

      • 대한민국

      • 기타 아시아 태평양

      • li>


    • 중동 및 아프리카

      • UAE

      • 사우디아라비아

      • 남아프리카

      • 나머지 중동 및 아프리카



    • 중남미

      • 브라질

      • 아르헨티나

      • 남미 및 중남미 중앙 아메리카




    회사 프로필





    • BASF SE

    • HUAZHONG PHARMACEUTICAL

    • Pfizer Inc.

    • MYLAN NV

    • Aeglea BioTherapeutics

    • Amino GMBH

    • KAO Corporation

    • DSM Corporation< /li>
    • 고아 기술

    • Fresenius Kabi AG


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the market CAGR value of Homocystinuria market during forecast period?

The global Homocystinuria market is expected to reach US$ 73,960.22 thousand by 2028 from US$ 56,589.20 thousand in 2021; it is estimated to grow at a CAGR of 3.9% during 2021-2028.

What are future trends of Homocystinuria market?

Emergence of human enzyme therapeutics and enzyme replacement therapy to treat rare disorders is one of the future trends of homocystinuria market. Enzyme replacement therapy and enzyme therapeutics is a type of novel drug therapy in which therapeutic enzymes are used to treat chronic and life-threatening diseases such as cancer, idiosyncratic disorders, and rare disorders. Furthermore, if an enzyme is not functioning properly in the body, then enzyme replacement therapy is used for replacing the enzyme that is deficient in the body. Enzymes have a predominant role in pharmaceutical industries and drug development as they treat various disorders. The advancements in the field of protein technology, recombinant DNA technology, enzyme immobilization, and nanotechnology have provided a solid platform for the use of enzymes in the treatment of various disorders.

What are the driving factors for the Homocystinuria market across the globe?

The growth of the Homocystinuria market is mainly attributed to factors such as the increasing prevalence of inherited metabolic disorders coupled with rise in vitamin B6 and Vitamin B12 deficiencies. However, the lack of awareness about various rare disorders and inherited metabolic disorders is hindering the market growth.

Which is the potential market for the Homocystinuria in terms of region??

The Asia Pacific region is expected to be the fastest-growing region among all other regions. The market in this region is expected to grow significantly in countries such as, China, Japan and India. The market is driven by increase in prevalence of inherited metabolic disorders, rise in government initiatives to manage rare diseases across the region along with increase in diagnostic tests across the region such as new born screening test etc. Therefore, the region holds huge potential for the homocystinuria market players to grow during the forecast period.

What does Homocystinuria mean?

Homocystinuria is an inherited disorder in which the body is unable to process certain building blocks of proteins (amino acids) properly. There are multiple forms of homocystinuria, which are distinguished by their signs and symptoms and genetic cause. The most common form of homocystinuria is characterized by nearsightedness (myopia), dislocation of the lens at the front of the eye, an increased risk of abnormal blood clotting, and brittle bones that are prone to fracture (osteoporosis) or other skeletal abnormalities. Some affected individuals also have developmental delay and learning problems.

The List of Companies - Homocystinuria Market

  1. BASF SE
  2. HUAZHONG PHARMACEUTICAL
  3. Pfizer Inc.
  4. MYLAN N.V
  5. Aeglea BioTherapeutics
  6. Amino GMBH
  7. KAO Corporation
  8. DSM Corporation
  9. Orphan Technologies
  10. Fresenius Kabi AG.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports